mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study
BioScience Trends · 2024
DOI: 10.5582/bst.2024.01286 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift BioScience Trends, 2024. Verfasst von Zhipeng Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Institute for Precision Medicine, Key Laboratory of Digital Intelligence Hepatolo…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Biliary Tract Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Institute for Precision Medicine, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), Tsinghua University; Research Unit of Prec…
- Department of Hepatopancreatobiliary Surgery, Affiliated Hospital, School of Clinical Medicine, Qinghai University, Xining, Qinghai, China.
Zitieren
APA
Sun, Z., Xu, H., Yang, L., Wang, X., Shu, B., Yang, M., Ren, Z., Xiang, C., Zhang, Y., & Yang, S. (2024). mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study. BioScience Trends. https://doi.org/10.5582/bst.2024.01286
Vancouver
Sun Z, Xu H, Yang L, Wang X, Shu B, Yang M, et al. mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study. BioScience Trends. 2024. doi:10.5582/bst.2024.01286
BibTeX
@article{Sun2024,
author = {Sun, Zhipeng and Xu, Hai and Yang, Lei and Wang, Xiaojuan and Shu, Bin and Yang, Ming and Ren, Zhizhong and Xiang, Canhong and Zhang, Yuewei and Yang, Shizhong},
title = {mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study},
journal = {BioScience Trends},
year = {2024},
doi = {10.5582/bst.2024.01286}
}
EUVIMED